NDA 005939 · Provepharm Sas
Bal
Dimercaprol · Injection
Last checked: Nov 20, 2026Latest source record: Mar 18, 2026 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1946
May 6, 1946
Approved uses
1
Original approval plus efficacy supplements
Registered trials
59
6 Phase 3, 6 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- May 6, 1946 Original approval
1 products under this application
- BAL · DIMERCAPROL 10% · INJECTABLE, INJECTION · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Dimercaprol" as an intervention, any sponsor and status, largest first.
- Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALPivotal-lookingRecruiting
Jena University HospitalAcademic, hospital or other
NCT06134492 · 616 participants (planned) · Start Feb 20, 2024 · Primary completion Jul 2026
Drug: Acyclovir · For: Pneumonia, Viral; Ventilator Associated Pneumonia; Community-acquired Pneumonia and 2 more
Sites: Freiburg im Breisgau, Germany; Heidelberg, Germany; Tübingen, Germany · 28 sites in all
- Balanced Analgosedation in Bronchoscopy: Propofol/Pethidine Versus Midazolam/PethidinePivotal-lookingNot yet recruiting
Fondazione Andrea Cesalpino Arezzo ONLUSAcademic, hospital or other
NCT06736938 · 530 participants (planned) · Start Apr 1, 2025 · Primary completion Apr 1, 2027
Drug: Propofol 1%; Midazolam and 1 more · For: Sedation During Bronchoscopy
Sites: Arezzo, Italy
- Trial of Oral Community SVMP INhibitors for SnakebitePivotal-lookingNot yet recruiting
Liverpool School of Tropical MedicineAcademic, hospital or other
NCT07500233 · 504 participants (planned) · Start Jan 2027 · Primary completion Oct 2028
Drug: 2,3-dimercapto-1-propanesulfonic acid; marimastat and 2 more · For: Snakebite
- Randomized Trial of COVID-19 Booster Vaccinations (Cobovax Study)Pivotal-lookingCompleted
The University of Hong KongAcademic, hospital or other
NCT05057169 · 451 participants · Start Nov 18, 2021 · Primary completion Dec 31, 2024
Drug: BNT162b2; CoronaVac · For: COVID-19 Vaccination
Sites: Hong Kong, Hong Kong
Second Affiliated Hospital, Zhejiang University, School of MedicineAcademic, hospital or other
NCT03957720 · 400 participants (planned) · Start Mar 15, 2019 · Primary completion Dec 31, 2024
Drug: DMPS; Penicillamine and 2 more · For: Wilson's Disease
Sites: Hangzhou, China
- Second-generation Sequencing Guides the Treatment of Severe PneumoniaPivotal-lookingStatus unknown
Xiangya Hospital of Central South UniversityAcademic, hospital or other
NCT03884881 · 400 participants · Start Jan 1, 2018 · Primary completion Dec 1, 2019
Drug: Meropenem,Imipenem,Caspofene,Osstat · For: Pneumonia; Metagenomic Next Generation Sequencing
Sites: Changsha, China
Benjamin MedoffAcademic, hospital or other
NCT00595491 · 313 participants (planned) · Start Jan 2008 · Primary completion Dec 31, 2029
Drug: Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage · For: Asthma
Sites: Boston, Massachusetts
- Drug Study of Albuterol to Treat Acute Lung InjuryPivotal-lookingTerminated
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT00434993 · 282 participants · Start Aug 2007 · Primary completion Sep 2008
Drug: Albuterol Sulfate; Placebo · For: Respiratory Distress Syndrome, Adult
Sites: Fresno, California; Sacramento, California; San Francisco, California · 40 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Interventions for paracetamol (acetaminophen) overdose.
Chiew AL, Gluud C, Brok J, et al. · Cochrane Database Syst Rev 2018 · Meta-Analysis, Research Support, Non-U.S. Gov't
- Diagnosis of ventilator-associated pneumonia in critically ill adult patients-a systematic review and meta-analysis.
Fernando SM, Tran A, Cheng W, et al. · Intensive Care Med 2020 · Meta-Analysis, Systematic Review
- Exercise Effects on Multiple Sclerosis Quality of Life and Clinical-Motor Symptoms.
Tollár J, Nagy F, Tóth BE, et al. · Med Sci Sports Exerc 2020 · Randomized Controlled Trial
- Interventions for paracetamol (acetaminophen) overdose.
Brok J, Buckley N, Gluud C · Cochrane Database Syst Rev 2006 · Meta-Analysis, Systematic Review
- Comparing the Effects of Progressive Balance and Hip Strengthening Rehabilitation in Individuals With Chronic Ankle Instability.
Suttmiller AMB, Johnson KR, Chung S, et al. · J Sport Rehabil 2025 · Randomized Controlled Trial, Comparative Study
- Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
Jain K, Wainwright CE, Smyth AR · Cochrane Database Syst Rev 2024 · Systematic Review, Research Support, Non-U.S. Gov't
Sponsor: Provepharm Sas
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.